+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Understanding and Applying ICH Q3A and Q3B for Control of Impurities in Drug Substances and Drug Products - Webinar

  • ID: 5212474
  • Webinar
  • December 2020
  • Region: Global
  • 90 Minutes
  • NetZealous LLC
25 % OFF
until May 05th 2021
Overview:

This course is designed to provide participants with an understanding of the regulatory expectations for controlling impurities and degradants (including DNA reactive/potential genotoxic impurities) in drug substances and drug products. There will be ample opportunity to discuss questions and challenges from the participants.

Why you should Attend: Upon completion of this course the learner should be able to:
  • Understand regulatory expectations regarding impurities, degradants and potential genotoxic impurities in pharmaceuticals
  • Understand what specifications will conform to regulatory expectations
  • Develop an process for reporting impurities and addressing OOS situations
Areas Covered in the Session:
  • Landscape of impurities requiring control in pharmaceutical products
  • General impurities: elemental impurities, residual solvents, microbiological
  • Drug-related impurities process impurities, degradants, potentially genotoxic impurities
  • Process Impurities
  • Understanding ICH Q3A
  • Where impurities originate
  • How impurities are characterized
  • How specifications are developed
  • How impurities should be reported
  • Degradants
  • Understanding ICH Q3B
  • Where degradants originate
  • How degradants are characterized
  • Potential genotoxic impurities
  • How specifications are developed
  • How degradants should be reported
  • Questions and discussion
Note: Product cover images may vary from those shown
Greg Martin is President of Complectors Consulting which provides consulting and training in the area of Pharmaceutical Analytical Chemistry. He has over 25 years experience in the pharmaceutical industry and was Director of Pharmaceutical Analytical Chemistry (R&D) for a major Pharma company for a number of years.

In addition, he has volunteered for the USP for over 10 years, and currently serves on the General Chapters - Chemical Analysis Expert Committee, and serves on Expert Panels on Validation and Verification, Residual Solvents and Use of Enzymes for Dissolution Testing of Gelatin Capsules.
Note: Product cover images may vary from those shown
  • Quality Engineers
  • Manufacturing Engineers
  • Internal Auditors
  • Quality Specialists
  • Quality Associates
  • Operations and Manufacturing Managers
  • Process Engineers
Note: Product cover images may vary from those shown
Adroll
adroll